Potential role of nuclear PD-L1 expression in cell-surface vimentin positive circulating tumor cells as a prognostic marker in cancer patients
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potential role of nuclear PD-L1 expression in cell-surface vimentin positive circulating tumor cells as a prognostic marker in cancer patients
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-07-01
DOI
10.1038/srep28910
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Circulating tumor cell enumeration by the CellSearch system: The clinician’s guide to breast cancer treatment?
- (2015) Nick Beije et al. CANCER TREATMENT REVIEWS
- The relevance of EMT in breast cancer metastasis: Correlation or causality?
- (2015) Ruben Bill et al. FEBS LETTERS
- Circulating tumor cells in breast cancer beyond the genotype of primary tumor for tailored therapy
- (2015) Chuanli Ren et al. INTERNATIONAL JOURNAL OF CANCER
- Frequent expression of PD-L1 on circulating breast cancer cells
- (2015) Martine Mazel et al. Molecular Oncology
- The significance of circulating tumor cells in prostate cancer patients undergoing adjuvant or salvage radiation therapy
- (2015) L E Lowes et al. PROSTATE CANCER AND PROSTATIC DISEASES
- EMT, CTCs and CSCs in tumor relapse and drug-resistance
- (2015) Abhisek Mitra et al. Oncotarget
- PDL1 expression in inflammatory breast cancer is frequent and predicts for the pathological response to chemotherapy
- (2015) François Bertucci et al. Oncotarget
- Prognostic and predictive value of PDL1 expression in breast cancer
- (2015) Renaud Sabatier et al. Oncotarget
- PDL1 expression is an independent prognostic factor in localized GIST
- (2015) François Bertucci et al. OncoImmunology
- Epithelial Plasticity in Cancer: Unmasking a MicroRNA Network for TGF-β-, Notch-, and Wnt-Mediated EMT
- (2015) Eugenio Zoni et al. Journal of Oncology
- PD-L1 and Survival in Solid Tumors: A Meta-Analysis
- (2015) Pin Wu et al. PLoS One
- Efficacy of Lapatinib in Therapy-Resistant HER2-Positive Circulating Tumor Cells in Metastatic Breast Cancer
- (2015) Sofia Agelaki et al. PLoS One
- Tracking viable circulating tumor cells (CTCs) in the peripheral blood of non-small cell lung cancer (NSCLC) patients undergoing definitive radiation therapy: Pilot study results
- (2014) Jay F. Dorsey et al. CANCER
- Universal Marker and Detection Tool for Human Sarcoma Circulating Tumor Cells
- (2014) Arun Satelli et al. CANCER RESEARCH
- Epithelial-Mesenchymal Transitioned Circulating Tumor Cells Capture for Detecting Tumor Progression
- (2014) A. Satelli et al. CLINICAL CANCER RESEARCH
- Circulating Tumor Cell Enumeration with a Combination of Epithelial Cell Adhesion Molecule- and Cell-Surface Vimentin-Based Methods for Monitoring Breast Cancer Therapeutic Response
- (2014) A. Satelli et al. CLINICAL CHEMISTRY
- Cytometric characterization of Circulating Tumor Cells Captured by microfiltration and their correlation to the cellsearch®CTC test
- (2014) Daniel L. Adams et al. CYTOMETRY PART A
- The biological and clinical importance of epithelial–mesenchymal transition in circulating tumor cells
- (2014) Huiying Liu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- B7-H3 expression in colorectal cancer: Nuclear localization strongly predicts poor outcome in colon cancer
- (2012) Vibeke Anett Ingebrigtsen et al. INTERNATIONAL JOURNAL OF CANCER
- The Potential of Circulating Tumor Cells as a Liquid Biopsy to Guide Therapy in Prostate Cancer
- (2012) Klaus Pantel et al. Cancer Discovery
- Therapeutic targeting of B7-H1 in breast cancer
- (2011) Amal Hasan et al. EXPERT OPINION ON THERAPEUTIC TARGETS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now